Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05574634 · ClinicalTrials.gov registry record · NA

The Role of the Locus Coeruleus in Age-related Distractibility

A NA study of Alzheimer Disease and Aging, sponsored by Virginia Polytechnic Institute and State University.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT05574634: Recruiting NA study of Alzheimer Disease and Aging, sponsored by Virginia Polytechnic Institute and State University.

NCT05574634 is a NA study of Alzheimer Disease and Aging that is actively recruiting participants, run by Virginia Polytechnic Institute and State University. The registered enrollment target is 200 participants, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05574634, a NA study of Alzheimer Disease and Aging, is actively recruiting participants, sponsored by Virginia Polytechnic Institute and State University.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

A growing body of research has highlighted the importance of frontal regions, at both the functional and structural levels, in age-related declines in attentional and cognitive processing. However, the underlying neurobiological pathophysiological changes in the brain that contribute to these declines are still largely unclear. The objective of this proposal is to investigate neural mechanisms of age-related attentional distractibility, focusing on the neural circuit initiated from the locus coeruleus (LC). In the current proposal, the investigators will test the hypothesis that the neural disconnectivity of LC with the salience network (SN) drives failures of ignoring distractors in older adults. The investigators will examine how LC-SN connectivity is associated with selective attention performance, and how improved LC-SN connectivity through a cognitive training program may lead to improved attentional performance.

Primary Outcome

During this task, participants will be presented to with target place stimuli overlaid on nonexpressive faces) and be asked to identify categories of place images ('building' to 'house') selectively as soon as possible while ignoring overlapped faces. The investigators will also include place only images to measure participants' baseline neural activation when there is no distractor. Each image condition will be presented in a mixed event related design that includes 15 blocks for each condition

Conditions Studied

Interventions

  • BEHAVIORAL Tablet based adaptive multimodal attention practice program
  • BEHAVIORAL Tablet based adaptive criterion task practice program

Study Locations (1)

Virginia

  • Virginia Polytechnic Institute and State University - Blacksburg

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2023-04-11
Est. Completion 2027-06-30
Phase NA

What NCT05574634 shows while recruiting

NCT05574634 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (93% lower).

The record links to 2 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 2 interventions - of which Tablet based adaptive multimodal attention practice program is the first listed.

NCT05574634 reports a single indexed study location in Virginia.

Frequently Asked Questions

What is clinical trial NCT05574634 about?

NCT05574634 is a clinical study titled "The Role of the Locus Coeruleus in Age-related Distractibility". A growing body of research has highlighted the importance of frontal regions, at both the functional and structural levels, in age-related declines in attentional and cognitive processing. However, the underlying neurobiological pathophysiological changes in the brain that contribute to these declin...

What is the current status of trial NCT05574634?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2023-04-11. Estimated completion is 2027-06-30.

What conditions does trial NCT05574634 study?

This clinical trial studies the following conditions: Alzheimer Disease, Aging.

What interventions are being tested in trial NCT05574634?

The interventions under investigation include: Tablet based adaptive multimodal attention practice program (BEHAVIORAL), Tablet based adaptive criterion task practice program (BEHAVIORAL).

Who is sponsoring clinical trial NCT05574634?

This trial is sponsored by Virginia Polytechnic Institute and State University, which has 104 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05574634 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05574634's enrollment target sits among peer trials

200 105th of 306 higher than 196 of 306 other Alzheimer Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Alzheimer Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05574634, the US trial registry maintained by the National Library of Medicine. NCT05574634 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.